{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:34:04Z","timestamp":1790796844495,"version":"4.1.0"},"reference-count":83,"publisher":"American Association for Cancer Research (AACR)","issue":"13","funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20ck0106442"],"award-info":[{"award-number":["JP20ck0106442"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["JP23K15313"],"award-info":[{"award-number":["JP23K15313"]}]},{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["22H03108"],"award-info":[{"award-number":["22H03108"]}]},{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["JP21H05051"],"award-info":[{"award-number":["JP21H05051"]}]},{"DOI":"10.13039\/100019356","name":"SGH Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MSD Life Science Foundation"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Foundation ARC pour la recherche sur le cancer","award":["#20151203514"],"award-info":[{"award-number":["#20151203514"]}]},{"name":"the France Lymphome Espoir association"},{"name":"the GEFLUC Paris-Ile de France"},{"name":"Institut Carnot CALYM"},{"name":"JANSSEN Horizon"},{"name":"Bristol-Myers Squibb Foundation"},{"name":"Agence Nationale de la Recherche under the Investissements d\u2019avenir program","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}]},{"name":"ITMO Cancer AVIESAN"},{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programme exploration Japon Sciences de la vie"},{"name":"French Institute of Health and Medical Research"},{"DOI":"10.13039\/100017682","name":"Japanese Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017682","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Imagine Institute"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Extranodal NK\/T-cell lymphoma (ENKTCL) is an Epstein\u2013Barr virus (EBV)\u2013related neoplasm with male dominance and a poor prognosis. A better understanding of the genetic alterations and their functional roles in ENKTCL could help improve patient stratification and treatments. In this study, we performed a comprehensive genetic analysis of 178 ENKTCL cases to delineate the landscape of mutations, copy number alterations (CNA), and structural variations, identifying 34 driver genes including six previously unappreciated ones, namely, HLA-B, HLA-C, ROBO1, CD58, POT1, and MAP2K1. Among them, CD274 (24%) was the most frequently altered, followed by TP53 (20%), CDKN2A (19%), ARID1A (15%), HLA-A (15%), BCOR (14%), and MSN (14%). Chromosome X losses were the most common arm-level CNAs in females (\u223c40%), and alterations of four X-linked driver genes (MSN, BCOR, DDX3X, and KDM6A) were more frequent in males and females harboring chromosome X losses. Among X-linked drivers, MSN was the most recurrently altered, and its expression was lost in approximately one-third of cases using immunohistochemical analysis. Functional studies of human cell lines showed that MSN disruption promoted cell proliferation and NF-\u03baB activation. Moreover, MSN inactivation increased sensitivity to NF-\u03baB inhibition in vitro and in vivo. In addition, recurrent deletions were observed at the origin of replication in the EBV genome (6%). Finally, by integrating the 34 drivers and 19 significant arm-level CNAs, nonnegative matrix factorization and consensus clustering identified two molecular groups with different genetic features and prognoses irrespective of clinical prognostic factors. Together, these findings could help improve diagnostic and therapeutic strategies in ENKTCL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Integrative genetic analyses and functional studies in extranodal NK\/T-cell lymphoma identify frequent disruptions of X-linked drivers, reveal prognostic molecular subgroups, and uncover recurrent MSN alterations that confer sensitivity to NF-\u03baB inhibition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-24-0132","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T14:17:24Z","timestamp":1713968244000},"page":"2181-2201","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK\/T-cell Lymphoma"],"prefix":"10.1158","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-4870","authenticated-orcid":false,"given":"Yuta","family":"Ito","sequence":"first","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"},{"name":"Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5707-7290","authenticated-orcid":false,"given":"Amira","family":"Marouf","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-5131","authenticated-orcid":false,"given":"Yasunori","family":"Kogure","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0605-1226","authenticated-orcid":false,"given":"Junji","family":"Koya","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-591X","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Li\u00e9vin","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-8489","authenticated-orcid":false,"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"},{"name":"Pathology Department, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8013-7327","authenticated-orcid":false,"given":"Mariko","family":"Tabata","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"},{"name":"Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2686-9604","authenticated-orcid":false,"given":"Yuki","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"},{"name":"Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4249-5000","authenticated-orcid":false,"given":"Sumito","family":"Shingaki","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2955-5803","authenticated-orcid":false,"given":"Mitsuhiro","family":"Yuasa","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"},{"name":"Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2165-8626","authenticated-orcid":false,"given":"Kentaro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"},{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-766X","authenticated-orcid":false,"given":"Koichi","family":"Murakami","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"},{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5235-0932","authenticated-orcid":false,"given":"Robert","family":"Weil","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, Institut National de la Sant\u00e9 et de la Recherche M\u00e9diicale (INSERM, UMR1135), Centre National de la Recherche Scientifique (CNRS, ERL8255), Centre d\u2019Immunologie et des Maladies Infectieuses CMI, Paris, France. 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2700-299X","authenticated-orcid":false,"given":"Manon","family":"Vavasseur","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0289-4952","authenticated-orcid":false,"given":"Guillaume P.","family":"Andrieu","sequence":"additional","affiliation":[{"name":"INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Universit\u00e9 Paris Cit\u00e9, Paris, France. 10"},{"name":"Laboratory of Onco-Hematology, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1520-4633","authenticated-orcid":false,"given":"Mehdi","family":"Latiri","sequence":"additional","affiliation":[{"name":"INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Universit\u00e9 Paris Cit\u00e9, Paris, France. 10"},{"name":"Laboratory of Onco-Hematology, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-4649","authenticated-orcid":false,"given":"Layla","family":"Veleanu","sequence":"additional","affiliation":[{"name":"INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Universit\u00e9 Paris Cit\u00e9, Paris, France. 10"},{"name":"Laboratory of Onco-Hematology, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6804-1621","authenticated-orcid":false,"given":"Micha\u00ebl","family":"Dussiot","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3905-9910","authenticated-orcid":false,"given":"Isabelle","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"Human Lymphohematopoiesis Lab, Universit\u00e9 Paris Cit\u00e9, Imagine Institute, INSERM UMR_S 1163, Paris, France. 12"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-8740","authenticated-orcid":false,"given":"Akshay","family":"Joshi","sequence":"additional","affiliation":[{"name":"Human Lymphohematopoiesis Lab, Universit\u00e9 Paris Cit\u00e9, Imagine Institute, INSERM UMR_S 1163, Paris, France. 12"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2216-6453","authenticated-orcid":false,"given":"Chantal","family":"Lagresle-Peyrou","sequence":"additional","affiliation":[{"name":"Biotherapy Clinical Investigation Center, Universit\u00e9 Paris Cit\u00e9, Imagine Institute, INSERM CIC 1416, Assistance Publique-Hopitaux de Paris, Paris, France. 13"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7365-699X","authenticated-orcid":false,"given":"Aude","family":"Magerus","sequence":"additional","affiliation":[{"name":"Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Universit\u00e9 Paris Cit\u00e9, Imagine Institute, INSERM UMR_S 1163, Paris, France. 14"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7465-9420","authenticated-orcid":false,"given":"Sammara","family":"Chaubard","sequence":"additional","affiliation":[{"name":"Hematology Department, Limoges University Hospital, Limoges, France. 15"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4737-1035","authenticated-orcid":false,"given":"David","family":"Lavergne","sequence":"additional","affiliation":[{"name":"Hematology Department, Limoges University Hospital, Limoges, France. 15"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-7510","authenticated-orcid":false,"given":"Emmanuel","family":"Bachy","sequence":"additional","affiliation":[{"name":"Hematology Department, Lyon Civils Hospices, Lyon, France. 16"},{"name":"Lymphoma Immuno-Biology (LIB) Team, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France. 17"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1726-4673","authenticated-orcid":false,"given":"Erika","family":"Brunet","sequence":"additional","affiliation":[{"name":"Laboratory of the Genome Dynamics in the Immune System, \u00c9quipe Lab\u00e9llis\u00e9e La Ligue Contre Le Cancer, Universit\u00e9 Paris Cit\u00e9, Paris Saclay University, INSERM UMR_S 1163, Imagine Institute, Paris, France. 18"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9503-0031","authenticated-orcid":false,"given":"Virginie","family":"Fataccioli","sequence":"additional","affiliation":[{"name":"Pathology Department, Henri Mondor University Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Cr\u00e9teil, France. 19"},{"name":"INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Cr\u00e9teil University, Cr\u00e9teil, France. 20"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7550-1270","authenticated-orcid":false,"given":"Chantal","family":"Brouzes","sequence":"additional","affiliation":[{"name":"INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Universit\u00e9 Paris Cit\u00e9, Paris, France. 10"},{"name":"Laboratory of Onco-Hematology, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-7512","authenticated-orcid":false,"given":"Camille","family":"Laurent","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer University Institute of Toulouse Oncopole, Toulouse, France. 21"},{"name":"Cancer Research Center of Toulouse, INSERM UMR 1037, ERL5294 CNRS, Toulouse III-Paul-Sabatier University, Toulouse, France. 22"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-516X","authenticated-orcid":false,"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland. 23"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3934-0120","authenticated-orcid":false,"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Lyon Sud Hospital, Claude Bernard Lyon-1 University, Pierre-B\u00e9nite, France. 24"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4513-0007","authenticated-orcid":false,"given":"C\u00e9line","family":"Bossard","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nantes University Hospital, Nantes, France. 25"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4335-4138","authenticated-orcid":false,"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[{"name":"Department of Pathology, Bordeaux University Hospital, Bordeaux University, Bordeaux, France. 26"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-9489","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Meignin","sequence":"additional","affiliation":[{"name":"Pathology Department, Saint Louis Hospital, Universit\u00e9 Paris Cit\u00e9, Paris, France. 27"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1121-2610","authenticated-orcid":false,"given":"Laure","family":"Philippe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Annecy Genevois Hospital, Epagny Metz-Tessy, France. 28"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-1424","authenticated-orcid":false,"given":"Julien","family":"Rossignol","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"},{"name":"Hematology Department, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 29"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-9052","authenticated-orcid":false,"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"},{"name":"Hematology Department, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 29"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-3331","authenticated-orcid":false,"given":"Jean-Marie","family":"Michot","sequence":"additional","affiliation":[{"name":"Drug Development Department, Gustave Roussy Institute, Paris-Saclay University, Villejuif, France. 30"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9438-621X","authenticated-orcid":false,"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France. 31"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4689-3882","authenticated-orcid":false,"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[{"name":"Department of Hematology, Caen University Hospital, Normandy University, Caen, France. 32"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6205-5419","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[{"name":"INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Cr\u00e9teil University, Cr\u00e9teil, France. 20"},{"name":"Hematology Department, Henri Mondor University Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Cr\u00e9teil, France. 33"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1935-3063","authenticated-orcid":false,"given":"Christine","family":"B\u00f4le-Feysot","sequence":"additional","affiliation":[{"name":"Genomics Core Facility, Imagine Institute-SFR Necker, INSERM U1163 and INSERM US24\/CNRS UAR3633, Universit\u00e9 Paris Cit\u00e9, Paris, France. 34"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2094-3298","authenticated-orcid":false,"given":"Patrick","family":"Nitschk\u00e9","sequence":"additional","affiliation":[{"name":"INSERM UMR_S 1163, Bioinformatics Platform, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 35"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0700-0240","authenticated-orcid":false,"given":"Bruno","family":"Tesson","sequence":"additional","affiliation":[{"name":"Bioinformatics Department, LYSARC, Pierre-B\u00e9nite, France. 36"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3022-2283","authenticated-orcid":false,"given":"C\u00e9cile","family":"Laurent","sequence":"additional","affiliation":[{"name":"Bioinformatics Department, LYSARC, Pierre-B\u00e9nite, France. 36"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3929-9754","authenticated-orcid":false,"given":"Thierry","family":"Molina","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"},{"name":"Pathology Department, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6255-5314","authenticated-orcid":false,"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[{"name":"INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Universit\u00e9 Paris Cit\u00e9, Paris, France. 10"},{"name":"Laboratory of Onco-Hematology, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1621-5134","authenticated-orcid":false,"given":"Yosaku","family":"Watatani","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan. 37"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-6998","authenticated-orcid":false,"given":"Kenichi","family":"Chiba","sequence":"additional","affiliation":[{"name":"Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan. 38"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9782-5900","authenticated-orcid":false,"given":"Ai","family":"Okada","sequence":"additional","affiliation":[{"name":"Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan. 38"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6144-5845","authenticated-orcid":false,"given":"Yuichi","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan. 38"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-0772","authenticated-orcid":false,"given":"Sachiko","family":"Tsukita","sequence":"additional","affiliation":[{"name":"Advanced Comprehensive Research Organization (ACRO), Teikyo University, Tokyo, Japan. 39"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-8057","authenticated-orcid":false,"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan. 40"},{"name":"Department of Hematology, Toranomon Hospital, Tokyo, Japan. 41"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-3725","authenticated-orcid":false,"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan. 42"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4996-5279","authenticated-orcid":false,"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan. 42"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2636-697X","authenticated-orcid":false,"given":"Seiji","family":"Sakata","sequence":"additional","affiliation":[{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. 43"},{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. 44"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. 45"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-2879","authenticated-orcid":false,"given":"Akito","family":"Dobashi","sequence":"additional","affiliation":[{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. 43"},{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. 44"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. 45"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-5800","authenticated-orcid":false,"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. 43"},{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. 44"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. 45"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0666-1996","authenticated-orcid":false,"given":"Masashi","family":"Sanada","sequence":"additional","affiliation":[{"name":"Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan. 46"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-905X","authenticated-orcid":false,"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"Pathology Department, Henri Mondor University Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Cr\u00e9teil, France. 19"},{"name":"INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Cr\u00e9teil University, Cr\u00e9teil, France. 20"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-8253","authenticated-orcid":false,"given":"Arnaud","family":"Jaccard","sequence":"additional","affiliation":[{"name":"Hematology Department, Limoges University Hospital, Limoges, France. 15"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7778-5374","authenticated-orcid":false,"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan. 37"},{"name":"Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan. 47"},{"name":"Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden. 48"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2574-3874","authenticated-orcid":false,"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"},{"name":"Hematology Department, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 29"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8263-9902","authenticated-orcid":false,"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. 1"},{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1357-5482","authenticated-orcid":false,"given":"Lucile","family":"Couronn\u00e9","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Universit\u00e9 Paris Cit\u00e9, Paris, France. 3"},{"name":"Laboratory of Onco-Hematology, Necker Children\u2019s Hospital, Assistance Publique - H\u00f4pitaux de Paris (APHP), Paris, France. 11"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"2026042014571517200_bib1","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the international peripheral T-cell lymphoma project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"2026042014571517200_bib2","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","article-title":"NK-\/T-cell lymphomas","volume":"35","author":"Wang","year":"2021","journal-title":"Leukemia"},{"key":"2026042014571517200_bib3","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S2352-3026(19)30283-2","article-title":"Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell project","volume":"7","author":"Fox","year":"2020","journal-title":"Lancet Haematol"},{"key":"2026042014571517200_bib4","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"key":"2026042014571517200_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol"},{"key":"2026042014571517200_bib6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41375-018-0324-5","article-title":"Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma","volume":"33","author":"Peng","year":"2019","journal-title":"Leukemia"},{"key":"2026042014571517200_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/cancers13030561","article-title":"Role of Epstein-Barr virus C promoter deletion in diffuse large B cell lymphoma","volume":"13","author":"Mabuchi","year":"2021","journal-title":"Cancers"},{"key":"2026042014571517200_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat Genet"},{"key":"2026042014571517200_bib9","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"2026042014571517200_bib10","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Nat Commun"},{"key":"2026042014571517200_bib11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","article-title":"Frequent BCOR aberrations in extranodal NK\/T-cell lymphoma, nasal type","volume":"55","author":"Dobashi","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"2026042014571517200_bib12","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"2026042014571517200_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm.4456","article-title":"Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK\/T cell lymphoma","volume":"24","author":"Wen","year":"2018","journal-title":"Nat Med"},{"key":"2026042014571517200_bib14","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","article-title":"Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas","volume":"33","author":"Kataoka","year":"2019","journal-title":"Leukemia"},{"key":"2026042014571517200_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"key":"2026042014571517200_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41379-019-0415-5","article-title":"Mutational profile and EBV strains of extranodal NK\/T-cell lymphoma, nasal type in Latin America","volume":"33","author":"Montes-Mojarro","year":"2020","journal-title":"Mod Pathol"},{"key":"2026042014571517200_bib17","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41375-022-01623-z","article-title":"Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer\/T-cell lymphoma","volume":"36","author":"Dong","year":"2022","journal-title":"Leukemia"},{"key":"2026042014571517200_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ajh.26636","article-title":"A genomic-augmented multivariate prognostic model for the survival of natural-killer\/T-cell lymphoma patients from an international cohort","volume":"97","author":"Lim","year":"2022","journal-title":"Am J Hematol"},{"key":"2026042014571517200_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"2026042014571517200_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-022-01293-5","article-title":"How we treat NK\/T-cell lymphomas","volume":"15","author":"Tse","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2026042014571517200_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"2026042014571517200_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"2026042014571517200_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol"},{"key":"2026042014571517200_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41375-020-0791-3","article-title":"Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making","volume":"35","author":"Chen","year":"2021","journal-title":"Leukemia"},{"key":"2026042014571517200_bib25","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"2026042014571517200_bib26","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"2026042014571517200_bib27","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French lymphopath network","volume":"35","author":"Laurent","year":"2017","journal-title":"J Clin Oncol"},{"key":"2026042014571517200_bib28","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1074\/jbc.274.4.2315","article-title":"Normal development of mice and unimpaired cell adhesion\/cell motility\/actin-based cytoskeleton without compensatory up-regulation of ezrin or radixin in moesin gene knockout","volume":"274","author":"Doi","year":"1999","journal-title":"J Biol Chem"},{"key":"2026042014571517200_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/cimm.1994.1150","article-title":"Restoration of lytic function in a human natural killer cell line by gene transfection","volume":"156","author":"Liu","year":"1994","journal-title":"Cell Immunol"},{"key":"2026042014571517200_bib30","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"2026042014571517200_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2026042014571517200_bib32","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"2026042014571517200_bib33","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"key":"2026042014571517200_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"2026042014571517200_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"key":"2026042014571517200_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"2026042014571517200_bib37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"key":"2026042014571517200_bib38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"2026042014571517200_bib39","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-02-768234","article-title":"Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)","volume":"130","author":"Park","year":"2017","journal-title":"Blood"},{"key":"2026042014571517200_bib40","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1093\/nar\/gkt126","article-title":"An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data","volume":"41","author":"Shiraishi","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026042014571517200_bib41","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"2026042014571517200_bib42","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell malignancies","volume":"108","author":"K\u00fc\u00e7\u00fck","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042014571517200_bib43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"2026042014571517200_bib44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s12864-019-6041-2","article-title":"SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events","volume":"20","author":"Bergstrom","year":"2019","journal-title":"BMC Genomics"},{"key":"2026042014571517200_bib45","first-page":"2","article-title":"Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor","volume":"9","author":"Ashiqul Islam","year":"2022","journal-title":"Cell Genom"},{"key":"2026042014571517200_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"2026042014571517200_bib47","doi-asserted-by":"crossref","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","article-title":"Distinct viral and mutational spectrum of endemic Burkitt lymphoma","volume":"11","author":"Abate","year":"2015","journal-title":"PLoS Pathog"},{"key":"2026042014571517200_bib48","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"2026042014571517200_bib49","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"2026042014571517200_bib50","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1073\/pnas.1608839114","article-title":"Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas","volume":"114","author":"Abate","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042014571517200_bib51","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.2021013568","article-title":"Whole-genome landscape of adult T-cell leukemia\/lymphoma","volume":"139","author":"Kogure","year":"2022","journal-title":"Blood"},{"key":"2026042014571517200_bib52","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042014571517200_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"2026042014571517200_bib54","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cell.2017.08.004","article-title":"NF-\u03baB c-Rel is crucial for the regulatory T cell immune checkpoint in cancer","volume":"170","author":"Grinberg-Bleyer","year":"2017","journal-title":"Cell"},{"key":"2026042014571517200_bib55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2017.08.010","article-title":"An NF-\u03baB transcription-factor-dependent lineage-specific transcriptional program promotes regulatory T cell identity and function","volume":"47","author":"Oh","year":"2017","journal-title":"Immunity"},{"key":"2026042014571517200_bib56","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3389\/fimmu.2019.02487","article-title":"The NF-\u03baB RelA transcription factor is critical for regulatory T cell activation and stability","volume":"10","author":"Ronin","year":"2019","journal-title":"Front Immunol"},{"key":"2026042014571517200_bib57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1083\/jcb.200807047","article-title":"Phospholipase C-mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane","volume":"184","author":"Hao","year":"2009","journal-title":"J Cell Biol"},{"key":"2026042014571517200_bib58","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat Methods"},{"key":"2026042014571517200_bib59","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cell.2017.11.008","article-title":"YY1 Is a structural regulator of enhancer-promoter loops","volume":"171","author":"Weintraub","year":"2017","journal-title":"Cell"},{"key":"2026042014571517200_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.stem.2013.03.006","article-title":"Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs","volume":"12","author":"Ding","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2026042014571517200_bib61","doi-asserted-by":"crossref","first-page":"e107377","DOI":"10.1371\/journal.pone.0107377","article-title":"Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector","volume":"9","author":"Rossi","year":"2014","journal-title":"PLoS One"},{"key":"2026042014571517200_bib62","doi-asserted-by":"crossref","first-page":"e2835","DOI":"10.21769\/BioProtoc.2835","article-title":"An image-based assay for high-throughput analysis of cell proliferation and cell death of adherent cells","volume":"8","author":"Szalai","year":"2018","journal-title":"Bio Protoc"},{"key":"2026042014571517200_bib63","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","article-title":"Maturation of mouse NK cells is a 4-stage developmental program","volume":"113","author":"Chiossone","year":"2009","journal-title":"Blood"},{"key":"2026042014571517200_bib64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat Genet"},{"key":"2026042014571517200_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","article-title":"Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation","volume":"130","author":"Schmidt","year":"2017","journal-title":"Blood"},{"key":"2026042014571517200_bib66","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrm882","article-title":"ERM proteins and merlin: integrators at the cell cortex","volume":"3","author":"Bretscher","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026042014571517200_bib67","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jaci.2016.04.032","article-title":"X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene","volume":"138","author":"Lagresle-Peyrou","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2026042014571517200_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s004180050262","article-title":"Differential expression of moesin in cells of hematopoietic lineage and lymphatic systems","volume":"110","author":"Masumoto","year":"1998","journal-title":"Histochem Cell Biol"},{"key":"2026042014571517200_bib69","doi-asserted-by":"crossref","first-page":"104456","DOI":"10.1016\/j.cellimm.2021.104456","article-title":"The ERM protein moesin regulates natural killer cell homeostasis in vivo","volume":"371","author":"Hiroki","year":"2022","journal-title":"Cell Immunol"},{"key":"2026042014571517200_bib70","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1128\/JVI.74.10.4512-4522.2000","article-title":"The minimal replicator of Epstein-Barr virus oriP","volume":"74","author":"Yates","year":"2000","journal-title":"J Virol"},{"key":"2026042014571517200_bib71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cell.2020.12.022","article-title":"Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance","volume":"184","author":"Dheekollu","year":"2021","journal-title":"Cell"},{"key":"2026042014571517200_bib72","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"2026042014571517200_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng.3726","article-title":"Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias","volume":"49","author":"Dunford","year":"2017","journal-title":"Nat Genet"},{"key":"2026042014571517200_bib74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0248-4900(00)01078-9","article-title":"ERM proteins: from cellular architecture to cell signaling","volume":"92","author":"Louvet-Vall\u00e9e","year":"2000","journal-title":"Biol Cell"},{"key":"2026042014571517200_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12929-016-0246-3","article-title":"A glimpse of the ERM proteins","volume":"23","author":"Ponuwei","year":"2016","journal-title":"J Biomed Sci"},{"key":"2026042014571517200_bib76","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.ejca.2012.06.003","article-title":"Bortezomib in combination with CHOP as first-line treatment for patients with stage III\/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial","volume":"48","author":"Kim","year":"2012","journal-title":"Eur J Cancer"},{"key":"2026042014571517200_bib77","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"key":"2026042014571517200_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13045-018-0559-7","article-title":"Activity of pembrolizumab in relapsed\/refractory NK\/T-cell lymphoma","volume":"11","author":"Li","year":"2018","journal-title":"J Hematol Oncol"},{"key":"2026042014571517200_bib79","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.2020007247","article-title":"Avelumab for the treatment of relapsed or refractory extranodal NK\/T-cell lymphoma: an open-label phase 2 study","volume":"136","author":"Kim","year":"2020","journal-title":"Blood"},{"key":"2026042014571517200_bib80","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.1038\/ncomms14257","article-title":"Epstein-Barr virus particles induce centrosome amplification and chromosomal instability","volume":"8","author":"Shumilov","year":"2017","journal-title":"Nat Commun"},{"key":"2026042014571517200_bib81","doi-asserted-by":"crossref","first-page":"e0174136","DOI":"10.1371\/journal.pone.0174136","article-title":"EBV induces persistent NF-\u03baB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells","volume":"12","author":"Takada","year":"2017","journal-title":"PLoS One"},{"key":"2026042014571517200_bib82","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1128\/JVI.00721-14","article-title":"MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1","volume":"88","author":"Jung","year":"2014","journal-title":"J Virol"},{"key":"2026042014571517200_bib83","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/s41375-020-1000-0","article-title":"Whole-genome sequencing identifies responders to pembrolizumab in relapse\/refractory natural-killer\/T cell lymphoma","volume":"34","author":"Lim","year":"2020","journal-title":"Leukemia"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-0132\/3445061\/can-24-0132.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/84\/13\/2181\/3469343\/can-24-0132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/84\/13\/2181\/3469343\/can-24-0132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:57:42Z","timestamp":1776711462000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/84\/13\/2181\/746131\/Comprehensive-Genetic-Profiling-Reveals-Frequent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":83,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,4,24]]},"published-print":{"date-parts":[[2024,7,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-0132","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.7311424.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.7311424","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.26144851.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.26144851","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.26144848.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.26144848","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]}}}